Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

• Main Authors: Ho, H.K., Németh, G., Ng, Y.R., Pang, E., Szántai-Kis, C., Zsákai, L., Breza, N., Greff, Z., Horváth, Z., Pató, J., Szabadkai, I., Szokol, B., Baska, F., Orfi, L., Ullrich, A., Kéri, G., Chua, B.T.
• 其他作者: PHARMACY
• 格式: Article
• 出版: 2014
• 主題: FGFR4; Inhibitor; Phosphorylation; Tyrosine Kinase
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/105815

10.2174/0929867311320100001